ArticleMolecular oncology2022

Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection.

Andi K Cani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.